Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study.

Ana Laura SoaresSérgio SimonLuiz Henrique GebrimAfonso Celso P NazárioMarise Lazaretti Castro

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)

The prevalence of MRONJ was 3% in women with metastatic breast cancer receiving BP. No cases were identified in women receiving oral BP chronically for osteoporosis. P1NP was higher in women with metastatic breast cancer, even during treatment with antiresorptives, but could not differentiate those with MRONJ.

Keyphrases

metastatic breast cancer
bone mineral density
risk factors
postmenopausal women
polycystic ovary syndrome
physical activity
healthcare
pregnancy outcomes
body composition
emergency department
type diabetes
cervical cancer screening
adipose tissue
pregnant women
skeletal muscle
metabolic syndrome